Is AOD-9604 legal in Australia?

AOD-9604 is not listed on the ARTG as a finished medicine, but it can be lawfully prescribed by an AHPRA-registered Australian doctor under the TGA Special Access Scheme Category B (SAS-B) and dispensed by a TGA-licensed Australian compounding pharmacy. Importing AOD-9604 yourself from offshore vendors remains illegal under the Customs Act.

How do I find a doctor who prescribes AOD-9604 in Australia?

Most GPs don't prescribe AOD-9604 because the SAS-B paperwork and compounding logistics fall outside routine general practice. The fastest pathway in 2026 is a peptide-specialist telehealth service — complete a clinical intake, an AHPRA-registered Australian doctor reviews your history, and if appropriate they lodge the SAS-B notification with the TGA.

How much does AOD-9604 cost in Australia per month?

Roughly AUD $200–$340 per month for the compounded vial from a TGA-licensed Australian pharmacy, plus a $99 initial telehealth consult. Final cost depends on dose and frequency set by your prescriber.

Is AOD-9604 the same as a GLP-1 like tirzepatide or semaglutide?

No. AOD-9604 is a growth-hormone fragment with proposed lipolytic activity. GLP-1 receptor agonists like tirzepatide and semaglutide have well-established weight-loss efficacy in clinical trials and are ARTG-registered for obesity in eligible patients. Your prescriber will decide which (if either) suits your case.

Is AOD-9604 banned in sport?

AOD-9604 is captured by WADA's S2 category (peptide hormones, growth factors, related substances). If you compete in WADA-tested sport, do not use it.

AHPRA-registered doctor · TGA SAS-B pathway

AOD-9604 in Australia

Get AOD-9604 — a modified C-terminal fragment of human growth hormone originally developed in Australia — prescribed lawfully under TGA SAS-B by an AHPRA-registered doctor. $99 initial telehealth consult, cold-chain dispense from a TGA-licensed Australian compounding pharmacy.

Start free 5-min assessment How it works

AHPRA-registered doctors

AOD-9604 is prescribed only after a clinical review by a registered Australian medical practitioner.

TGA SAS-B pathway

AOD-9604 isn't on the ARTG, but Australian doctors can lawfully prescribe it under SAS-B with a TGA notification.

Australian compounding

Compounded by a TGA-licensed Australian pharmacy under PIC/S GMP — batch-tested for identity, sterility, and potency.

What is AOD-9604?

AOD-9604 is a synthetic 16-amino-acid analogue of the C-terminal lipolytic fragment of human growth hormone (residues 176-191). It was originally developed at Monash University in Melbourne as an "anti-obesity" candidate — hence the AOD prefix — and is one of the few peptides with an Australian research lineage.

AOD-9604 is not listed on the Australian Register of Therapeutic Goods (ARTG) as a finished medicine. An AHPRA-registered Australian doctor can lawfully prescribe it under the TGA Special Access Scheme Category B (SAS-B) for individual patients, with the medicine compounded by a TGA-licensed Australian compounding pharmacy. It is sometimes used as an adjunct alongside diet, exercise, and (where appropriate) GLP-1 therapy — not as a standalone weight-loss drug.

Typical clinical indications

Adjunctive fat-loss support alongside diet and exercise (per-case)
Body-composition support in metabolically healthy adults under clinician guidance
Research interest in cartilage and joint applications (off-label, per-case)

Administration

Typically subcutaneous injection, daily or 5-on-2-off, often in the morning before fasted activity. Dose, frequency, and cycle length are individualised by the prescriber — there is no universal protocol.

Cautions and contraindications

Not for use in pregnancy, breastfeeding, or with active malignancy. AOD-9604 is not a substitute for GLP-1 medications in clinically indicated obesity. Discuss any pre-existing conditions and current medications at consult.

How to get AOD-9604 prescribed in Australia

1. Free 5-minute pre-qualification
Answer screening questions about your history, goals, and current medications. Instant suitability check.
2. $99 telehealth consult
Video or phone consult with an AHPRA-registered Australian doctor. They review eligibility and confirm dosing.
3. SAS-B script issued (24–48 hours)
Doctor lodges a TGA SAS-B notification and routes the script to a TGA-licensed Australian compounding pharmacy.
4. Cold-chain dispense (2–4 business days)
Pharmacy ships cold-chain Mon–Wed. Includes vials, syringes, alcohol swabs, and a starter guide.

Do not import AOD-9604 from overseas

Importing AOD-9604 yourself from offshore "research chemical" vendors is illegal under the Customs Act, gives no guarantee of sterility or potency, and leaves you with no Australian doctor if something goes wrong. The lawful path is AHPRA-registered doctor → TGA SAS-B → TGA-licensed Australian compounding pharmacy. See why staying local matters.

AOD-9604 Australia — FAQs

Is AOD-9604 legal in Australia?: AOD-9604 is not listed on the ARTG as a finished medicine, but it can be lawfully prescribed by an AHPRA-registered Australian doctor under the TGA Special Access Scheme Category B (SAS-B) and dispensed by a TGA-licensed Australian compounding pharmacy. Importing AOD-9604 yourself from offshore vendors remains illegal under the Customs Act.
How do I find a doctor who prescribes AOD-9604 in Australia?: Most GPs don't prescribe AOD-9604 because the SAS-B paperwork and compounding logistics fall outside routine general practice. The fastest pathway in 2026 is a peptide-specialist telehealth service — complete a clinical intake, an AHPRA-registered Australian doctor reviews your history, and if appropriate they lodge the SAS-B notification with the TGA.
How much does AOD-9604 cost in Australia per month?: Roughly AUD $200–$340 per month for the compounded vial from a TGA-licensed Australian pharmacy, plus a $99 initial telehealth consult. Final cost depends on dose and frequency set by your prescriber.
Is AOD-9604 the same as a GLP-1 like tirzepatide or semaglutide?: No. AOD-9604 is a growth-hormone fragment with proposed lipolytic activity. GLP-1 receptor agonists like tirzepatide and semaglutide have well-established weight-loss efficacy in clinical trials and are ARTG-registered for obesity in eligible patients. Your prescriber will decide which (if either) suits your case.
Is AOD-9604 banned in sport?: AOD-9604 is captured by WADA's S2 category (peptide hormones, growth factors, related substances). If you compete in WADA-tested sport, do not use it.

Related Australian peptide pages

Start with the legality hub if you're new to TGA SAS-B prescribing, or browse the other Australian peptide landings.

Are peptides legal in Australia? — TGA SAS-B explained Free 60-sec eligibility checker

Medically reviewed by the PeptideDoctorAU Medical Review Panel — last reviewed 29 May 2026. See the panel.

Start your AOD-9604 consult — $99

Take the free 5-minute pre-qualification. If you're suitable, you'll be matched with an AHPRA-registered Australian doctor for a $99 telehealth consult — TGA SAS-B prescribing, Australian-compounded vial.

Start free assessment